Skip to main content
logo
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
23.69
-1.36 (-5.43%)
At close: Jun 5, 2026, 4:00 PM EDT
23.69
0.00 (0.00%)
After-hours: Jun 5, 2026, 4:58 PM EDT

Mineralys Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
112.78172.92114.0949.387.710.61
Short-Term Investments
533.28483.7184.1187.2622.41-
Cash & Short-Term Investments
646.06656.64198.19236.57110.1110.61
Cash Growth
88.34%231.32%-16.22%114.85%937.60%653.16%
Other Current Assets
6.414.757.1612.542.70.51
Total Current Assets
652.47661.39205.35249.1112.8111.12
Net Property, Plant & Equipment
0.030.040.05---
Long-Term Investments
---2.48--
Other Long-Term Assets
0.360.380.50.051.630
Total Assets
652.86661.81205.9251.64114.4411.13
Accounts Payable
1.122.020.480.61.910.76
Accrued Expenses
13.613.114.179.886.164.29
Total Current Liabilities
14.7215.1114.6510.488.075.05
Total Liabilities
14.7215.1114.6510.488.075.05
Common Stock
0.010.010.01000
Additional Paid-in Capital
1,1351,104493.77365.860.540.09
Retained Earnings
-496.51-457.17-302.52-124.71-52.81-23.01
Total Common Shareholders' Equity
638.14646.69191.26241.15-52.27-22.93
Minority Interest
----158.6429
Shareholders' Equity
638.14646.69191.26241.15106.386.07
Total Liabilities & Equity
652.86661.81205.9251.64114.4411.13
Net Cash (Debt)
646.06656.64198.19236.57110.1110.61
Net Cash Growth
-1.61%231.32%-16.22%114.85%937.60%-
Net Cash Per Share
8.639.714.086.5421.312.13
Book Value
638.14646.69191.26241.15-52.27-22.93
Book Value Per Share
8.529.563.946.66-10.12-4.60
Tangible Book Value
638.14646.69191.26241.15-52.27-22.93
Tangible Book Value Per Share
8.529.563.946.66-10.12-4.60
SEC Filings: 10-K · 10-Q